Clinical features of pregnancy in multidrug-resistant tuberculosis and type I diabetes mellitus comorbidities (a case report).

Authors

  • O. M. Raznatovska
  • A. V. Fedorec
  • M. O. Shalmina
  • T. A. Grekova

DOI:

https://doi.org/10.26641/2307-0404.2019.3.181890

Keywords:

pregnancy, multidrug-resistant tuberculosis, type 1 diabetes mellitus

Abstract

Objective – to update the literature data with the clinical features of pregnancy in multidrug-resistant tuberculosis (MRD-TB) and type 1 diabetes mellitus (T1DM) comorbidities based on an example from own clinical experience. A clinical case of pregnancy course in MRD-TB and T1DM comorbidities was described based on our own clinical experience. We report the clinical case of newly diagnosed MRD-TB in a 38-year-old woman suffering from T1DM. Her general condition was unstable from satisfactory to moderately severe despite an adequate treatment of MRD-TB and T1DM with manifestations of intoxication syndrome and nephropathy. Adenomyosis with periodic bloody vaginal discharge was diagnosed. There was no clinical-radiological dynamics and sputum culture conversion. After an intensive phase of antimycobacterial therapy within 3 months, the patient got pregnant. Based on the medical indications (MRD-TB, absence of sputum culture conversion and clinical-radiological dynamics, moderate severity of T1DM, nephropathy) and adenomyosis with bloody vaginal discharge, the patient was requested to induce the pregnancy termination, and she consented. On month 7 of antimycobacterial therapy, an extensive drug-resistance of Mycobacterium tuberculosis to antimycobacterial agents and negative dynamics by follow-up chest X-ray were diagnosed. The feature of pregnancy course in MRD-TB and T1DM comorbidities was an unfavorable coexistence of both these diseases simultaneously resulting in an induced abortion. In this case, doctors to working with patients suffering from both MRD-TB and T1DM are recommended to advise patients the use of contraception in order to prevent pregnancy during treatment of active MRD-TB.

Author Biographies

O. M. Raznatovska

Zaporizhzhia State Medical University 1
Maiakovskyi av., 26, Zaporizhzhia, 69035, Ukraine

A. V. Fedorec

MI «Zaporizhzhia Regional TB Clinical Dispensary» 2
Perspektyvna, 2, Zaporizhzhia, 69106, Ukraine
Запорізький державний медичний університет 

M. O. Shalmina

Zaporizhzhia State Medical University 1
Maiakovskyi av., 26, Zaporizhzhia, 69035, Ukraine

T. A. Grekova

Zaporizhzhia State Medical University 1
Maiakovskyi av., 26, Zaporizhzhia, 69035, Ukraine

References

Jakovlev AA, Mordyk AV, Zhukova NV, Antro­pova VV, Leont'ev VV, Nikolaeva II. [Analysis of the course and outcome of tuberculosis and pregnancy when they are combined in patients of reproductive age]. Sibir­skoe medicinskoe obozrenie [Internet]. 2012;1(73). Russian. Available from: https://cyberleninka.ru/article/n/analiz-techeniya-i-ishodov-tuberkuleza-i-beremennosti-pri-ih-sochetanii-u-patsientok-reproduktivnogo-vozrasta.

Rahimdzhanova MT, Ismailov SI, Tashmano­va AB, Ahmedova MS. [The study of the course of preg­nancy and its outcomes with the analysis of possible risk factors in patients with type 1 diabetes]. Mezhdunarodnyi endokrinologicheskii zhurnal. 2014;2(58):28-30. Russian.

Nikonova LV, Tishkovskaja SV, Gadomskaja VI, Davydchik JV, Gulinskaja OV. [Diabetes and pregnancy. Part II. Course, patient management tactics]. J of the Grodno State Medical University. 2017;15(4):368-74. Russian. doi: https://doi.org/10.25298/2221-8785-2017-15-4-368-374.

Torosian KJ, Nepso JR, Novikova VA, Pen­zhojan GA. [Diabetes mellitus type 1 and pregnancy: a clinical perspective]. Sovremennye problemy nauki i obrazovanija [Internet]. 2016;4. Russian. Available from: http://www.science-education.ru/ru/article/view?id=24998.

[Unified clinical protocols of primary, secondary (specialized) and tertiary (highly specialized) medical care for adults "Tuberculosis": Ministry of Health of Ukraine Order No. 620 of December 31, 2014]. Kyiv, MOZ Ukrainy. 2014;171. Ukrainian.

Riza AL, Pearson F, Ugarte-Gil C, Alisjahbana B, van de Vijver S, Panduru NM, et al. Clinical management of concurrent diabetes and tuberculosis and the impli­cations for patient services. Lancet Diabetes Endocrinol. 2014;2(9):740-53.

Global report on diabetes. Geneva: World Health Organization. 2016;86.

Global Tuberculosis Report 2018. Geneva: World Health Organization. 2019;174.

Murphy HR, Elleri D, Allen JM, Harris J, Simmons D, Rayman G, et al. Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes. Diabetes Care. 2011;34:406-11. doi: https://doi.org/10.2337/dc10-1796

Rohilla M, Joshi B, Jain V, Kalra J, Prasad GRV. Multidrug-Resistant Tuberculosis during Pregnancy: Two Case Reports and Review of the Literature. Case Rep Obstet Gynecol. 2016:4. doi: https://doi.org/10.1155/2016/1536281

Gadallah MA, Mokhtar A, Rady M, El-Moghazy E, Fawzy M, Kandil SK. Prognostic factors of treatment among patients with multidrug-resistant tuberculosis in Egypt. J Formos Med Assoc. 2016;115(11):997-1003. doi: https://doi.org/10.1016/j.jfma.2015.10.002

Siddiqui A. Role of Diabetes in prevalence of Tuberculosis. J Diabetes Metab. 2011;2(9):170. doi: https://doi.org/10.4172/2155-6156.1000170

Downloads

How to Cite

1.
Raznatovska OM, Fedorec AV, Shalmina MO, Grekova TA. Clinical features of pregnancy in multidrug-resistant tuberculosis and type I diabetes mellitus comorbidities (a case report). Med. perspekt. [Internet]. 2019Nov.5 [cited 2024Apr.17];24(3):101-5. Available from: https://journals.uran.ua/index.php/2307-0404/article/view/181890

Issue

Section

CLINICAL MEDICINE